Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

TG6-10-1 1 mg  | ≥98%

Cayman Chemical

A potent EP2 receptor antagonist

More Information Supplier Page

×

TG6-10-1

TG6-129 5 mg  | ≥98%

Cayman Chemical

An antagonist of the EP2 receptor

More Information Supplier Page

×

TG6-129

TG6-129 1 mg  | ≥98%

Cayman Chemical

An antagonist of the EP2 receptor

More Information Supplier Page

×

TG6-129

TG6-129 500 µg  | ≥98%

Cayman Chemical

An antagonist of the EP2 receptor

More Information Supplier Page

×

TG6-129

TG89 1 mg  | ≥95%

Cayman Chemical

A JAK2 inhibitor

More Information Supplier Page

×

TG89

TG89 10 mg  | ≥95%

Cayman Chemical

A JAK2 inhibitor

More Information Supplier Page

×

TG89

TG89 25 mg  | ≥95%

Cayman Chemical

A JAK2 inhibitor

More Information Supplier Page

×

TG89

TG89 5 mg  | ≥95%

Cayman Chemical

A JAK2 inhibitor

More Information Supplier Page

×

TG89

TGN 020 100 mg  | ≥98%

Cayman Chemical

An AQP4 inhibitor

More Information Supplier Page

×

TGN 020

TGN 020 50 mg  | ≥98%

Cayman Chemical

An AQP4 inhibitor

More Information Supplier Page

×

TGN 020

TGN 020 25 mg  | ≥98%

Cayman Chemical

An AQP4 inhibitor

More Information Supplier Page

×

TGN 020

TGN 020 10 mg  | ≥98%

Cayman Chemical

An AQP4 inhibitor

More Information Supplier Page

×

TGN 020

TGN 073 10 mg  | ≥98%

Cayman Chemical

An AQP4 facilitator

More Information Supplier Page

×

TGN 073

TGN 073 100 mg  | ≥98%

Cayman Chemical

An AQP4 facilitator

More Information Supplier Page

×

TGN 073

TGN 073 5 mg  | ≥98%

Cayman Chemical

An AQP4 facilitator

More Information Supplier Page

×

TGN 073

TGN 073 50 mg  | ≥98%

Cayman Chemical

An AQP4 facilitator

More Information Supplier Page

×

TGN 073

TGR-1202 100 mg  | ≥98%

Cayman Chemical

A PI3K p110d inhibitor

More Information Supplier Page

×

TGR-1202

TGR-1202 50 mg  | ≥98%

Cayman Chemical

A PI3K p110d inhibitor

More Information Supplier Page

×

TGR-1202

TGR-1202 25 mg  | ≥98%

Cayman Chemical

A PI3K p110d inhibitor

More Information Supplier Page

×

TGR-1202

TGR-1202 5 mg  | ≥98%

Cayman Chemical

A PI3K p110d inhibitor

More Information Supplier Page

×

TGR-1202

TGR5 Receptor Agonist 25 mg  | ≥98%

Cayman Chemical

A TGR5 agonist

More Information Supplier Page

×

TGR5 Receptor Agonist

TGR5 Receptor Agonist 10 mg  | ≥98%

Cayman Chemical

A TGR5 agonist

More Information Supplier Page

×

TGR5 Receptor Agonist

TGR5 Receptor Agonist 5 mg  | ≥98%

Cayman Chemical

A TGR5 agonist

More Information Supplier Page

×

TGR5 Receptor Agonist

TGR5 Receptor Agonist 1 mg  | ≥98%

Cayman Chemical

A TGR5 agonist

More Information Supplier Page

×

TGR5 Receptor Agonist

TGX-221 10 mg  | ≥98%

Cayman Chemical

A potent, selective PI3K inhibitor

More Information Supplier Page

×

TGX-221

TGX-221 5 mg  | ≥98%

Cayman Chemical

A potent, selective PI3K inhibitor

More Information Supplier Page

×

TGX-221

TGX-221 1 mg  | ≥98%

Cayman Chemical

A potent, selective PI3K inhibitor

More Information Supplier Page

×

TGX-221

TGX-221 500 µg  | ≥98%

Cayman Chemical

A potent, selective PI3K inhibitor

More Information Supplier Page

×

TGX-221

TH-1760 10 mg  | ≥95%

Cayman Chemical

A NUDT15 inhibitor

More Information Supplier Page

×

TH-1760

TH-1760 25 mg  | ≥95%

Cayman Chemical

A NUDT15 inhibitor

More Information Supplier Page

×

TH-1760

TH-1760 5 mg  | ≥95%

Cayman Chemical

A NUDT15 inhibitor

More Information Supplier Page

×

TH-1760

TH-1760 50 mg  | ≥95%

Cayman Chemical

A NUDT15 inhibitor

More Information Supplier Page

×

TH-1760

TH-302 25 mg  | ≥95%

Cayman Chemical

A hypoxia-activated anticancer agent

More Information Supplier Page

×

TH-302

TH-302 10 mg  | ≥95%

Cayman Chemical

A hypoxia-activated anticancer agent

More Information Supplier Page

×

TH-302

TH-302 5 mg  | ≥95%

Cayman Chemical

A hypoxia-activated anticancer agent

More Information Supplier Page

×

TH-302

TH-302 1 mg  | ≥95%

Cayman Chemical

A hypoxia-activated anticancer agent

More Information Supplier Page

×

TH-302

TH1020 50 mg  | ≥98%

Cayman Chemical

An inhibitor of the TLR5-flagellin protein-protein interaction

More Information Supplier Page

×

TH1020

TH1020 25 mg  | ≥98%

Cayman Chemical

An inhibitor of the TLR5-flagellin protein-protein interaction

More Information Supplier Page

×

TH1020

TH1020 10 mg  | ≥98%

Cayman Chemical

An inhibitor of the TLR5-flagellin protein-protein interaction

More Information Supplier Page

×

TH1020

TH1020 5 mg  | ≥98%

Cayman Chemical

An inhibitor of the TLR5-flagellin protein-protein interaction

More Information Supplier Page

×

TH1020

TH257 50 mg  | ≥98%

Cayman Chemical

An inhibitor of LIMK1 and LIMK2

More Information Supplier Page

×

TH257

TH257 25 mg  | ≥98%

Cayman Chemical

An inhibitor of LIMK1 and LIMK2

More Information Supplier Page

×

TH257

TH257 10 mg  | ≥98%

Cayman Chemical

An inhibitor of LIMK1 and LIMK2

More Information Supplier Page

×

TH257

TH257 5 mg  | ≥98%

Cayman Chemical

An inhibitor of LIMK1 and LIMK2

More Information Supplier Page

×

TH257

TH263 10 mg  | ≥98%

Cayman Chemical

An inactive analog of TH257

More Information Supplier Page

×

TH263

TH263 25 mg  | ≥98%

Cayman Chemical

An inactive analog of TH257

More Information Supplier Page

×

TH263

TH263 5 mg  | ≥98%

Cayman Chemical

An inactive analog of TH257

More Information Supplier Page

×

TH263

TH263 50 mg  | ≥98%

Cayman Chemical

An inactive analog of TH257

More Information Supplier Page

×

TH263

TH287 10 mg  | ≥98%

Cayman Chemical

A selective MTH1 inhibitor

More Information Supplier Page

×

TH287

TH287 5 mg  | ≥98%

Cayman Chemical

A selective MTH1 inhibitor

More Information Supplier Page

×

TH287